Alere Announces Management Transition

                    Alere Announces Management Transition

Ron Zwanziger Resigns as Chief Executive Officer and President; Namal Nawana
Appointed Interim CEO

PR Newswire

WALTHAM, Mass., July 1, 2014

WALTHAM, Mass., July 1, 2014 /PRNewswire/ --Alere Inc. (NYSE: ALR), a global
leader in empowering individuals to take greater control of their health at
home by connecting innovative diagnostics in the hands of patients to their
healthcare providers, today announced as part of its ongoing review of its
strategy and operations, that Chief Operating Officer Namal Nawana has been
appointed interim Chief Executive Officer and President following the
resignation of Ron Zwanziger as Chief Executive Officer, Presidentand a
director of the Company, effective immediately. Jerry McAleer, Senior Vice
President Research and Development and a director, and Dave Scott, Chief
Scientific Officer, also resigned effective immediately.

The Alere Board of Directors will initiate a search process and plans to
retain a leading executive search firm to identify a permanent CEO and
President. The search process will include a review of both internal and
external candidates. Mr. Nawana will maintain his current responsibilities as
COO during the transition period.

"On behalf of the entire Alere Board, I would like to thank Ron, Jerry and
Dave for their years of leadership," said Gregg J. Powers, Chairman of Alere's
Board. "Since founding the Company in 2001, Ron, Jerry and Dave have led
Alere's growth into a leading global healthcare company providing
point-of-care diagnostics, health information systems and chronic care
management programs. We believe that with Alere's talented management team in
place, now is the right time for the Company to transition to new leadership."

"I am delighted that Namal, Alere's COO since December 2012, has agreed to
serve as Interim CEO. Namal's significant operational experience in the
healthcare industry makes him an excellent choice to fill the CEO role while
the Board commences its search for a permanent CEO."

About Namal Nawana
Namal Nawanahas served as Alere's Chief Operating Officer since December
2012. Before joining Alere, Mr. Nawana spent 15 years at Johnson & Johnson in
various leadership roles. Most recently, he served as the Worldwide President
of DePuy Synthes Spine, a Johnson & Johnson company. Prior to that, Mr. Nawana
was Area Vice President for Johnson & Johnson Medical's operations in
Australia and New Zealand, Chairman of the DePuy Asia Pacific Franchise
Council, General Manager for DePuy Australia and General Manager for DePuy
Canada. Mr. Nawana holds a Masters of Medical Science from the University of
Adelaide and an MBA from the Henley Business School.

About Alere
By developing new capabilities in near-patient diagnosis, monitoring and
health information technology, Alere enables individuals to take charge of
improving their health and quality of life at home. Alere's global leading
products and services, as well as its new product development efforts, focus
on infectious disease, toxicology, cardiology and diabetes. Alere is
headquartered in Waltham, Massachusetts. For more information regarding Alere,
please visit

SOURCE Alere Inc.

Contact: Media, Jackie Lustig, Director, Corporate Communications,, 781-314-4009, or Dan Katcher / Kelly Sullivan / Dan
Moore, Joele Frank, Wilkinson Brimmer Katcher, 212-355-4449
Press spacebar to pause and continue. Press esc to stop.